Meliá Hotels International, S.A. (BME:MEL)
Spain
· Delayed Price · Currency is EUR | Market Cap | 2.48B |
| Revenue (ttm) | 2.08B |
| Net Income (ttm) | 170.07M |
| Shares Out | 220.19M |
| EPS (ttm) | 0.77 |
| PE Ratio | 14.65 |
| Forward PE | 15.60 |
| Dividend | 0.14 (1.27%) |
| Ex-Dividend Date | n/a |
| Volume | 426,217 |
| Average Volume | 587,317 |
| Open | 11.42 |
| Previous Close | 11.28 |
| Day's Range | 10.97 - 11.42 |
| 52-Week Range | 6.14 - 11.59 |
| Beta | 0.69 |
| RSI | 65.03 |
| Earnings Date | May 7, 2026 |
About BME:MEL
Meliá Hotels International, S.A. owns, operates, manages, leases, and franchises hotels in Spain, Latin America, the rest of Europe, and Asia. It operates through Hotel Management, Hotel Business, Other Business Linked to Hotel Management, and Real Estate segments. The company operates hotels under the Gran Meliá Hotels & Resorts, the Meliá Collection, ME by Meliá, Paradisus by Meliá, Meliá Hotels & Resorts, INNSIDE by Meliá, ZEL, Sol by Meliá, Affiliated by Meliá brands, as well as Circle by Meliá and Club Meliá brands. It also engages in the ... [Read more]
Financial Performance
In 2025, BME:MEL's revenue was 2.08 billion, an increase of 3.22% compared to the previous year's 2.01 billion. Earnings were 170.07 million, an increase of 20.94%.
Financial StatementsNews
Meliá Hotels International Earnings Call Transcript: Q4 2025
Delivered strong RevPAR and net profit growth in 2025, supported by robust demand, disciplined pricing, and successful expansion in key markets. Outlook for 2026 remains positive, with continued investment, margin improvement, and a stable financial position.
Meliá Hotels International Earnings Call Transcript: Q2 2025
Strong first-half results with 4.7% RevPAR and 3.1% revenue growth, driven by Spain and luxury segments. Net profit rose 72.4% to €88.5M, and guidance for mid-single-digit RevPAR growth and 100 bps EBITDA margin improvement is reaffirmed. Asset-light expansion and stable leverage remain priorities.
Meliá Hotels International Transcript: AGM 2025
Record financial results in 2023 enabled the return to dividends and strong expansion plans for 2024, with a focus on premium segments, digitalization, and sustainability. All resolutions, including dividend distribution and governance updates, were approved by a large majority.
Meliá Hotels International Earnings Call Transcript: Q4 2024
Achieved double-digit RevPAR growth and surpassed EBITDA targets in 2024, driven by strong leisure demand, price increases, and successful asset rotation. Net debt reduced by EUR 400 million, with a positive outlook for 2025 and plans for further expansion and increased dividends.
Meliá Hotels International Transcript: AGM 2024
Meliá Hotels International Earnings Call Transcript: Q4 2023
Meliá Hotels International Earnings Call Transcript: Q4 2022
Jim Cramer gives his take on big banks' earnings
Jim Cramer, Mad Money host, joins 'Squawk Box' to discuss his first take on Mad Money's move to NYSE and big banks' earning reports.
Domestic and international flights see 40% and 25% price hikes over last three months
CNBC's Seema Mody reports on the return of business travel. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/Subsc...
Meliá Hotels International Earnings Call Transcript: Q4 2021
Pro: stay away from hotels and airlines stocks until more clarity
A sharp surge in new COVID-19 cases is sending Europe into another lockdown, and Veritas Financial Group's Greg Branch says turning to reopening names might not be the best way to go yet. Greg Branch'...
Travel industry prepare for boom as US lifts travel restrictions
As the U.S. eases international travel restrictions for 33 countries, Yahoo Finance's Emily McCormick, Brian Sozzi, and Julie Hyman discuss how hotels, airlines, ride-sharing companies, and retail can...
Meliá Hotels International Earnings Call Transcript: Q2 2021
Investors eye shares of hotels, cruise lines as U.S. vaccinations pick up
Investors are watching next week's earnings reports from hotels, cruise lines and other businesses that have been hard hit by COVID-19 for indications of which companies could be the first to bounce b...
Francisco Garcia Parames' Top 5 4th-Quarter Trades
Cobas Asset Management, the firm founded by Francisco Garcia Parames (Trades, Portfolio), disclosed this week that its top five trades during the fourth quarter of 2020 include position boosts in Atal...
If corporate travel is delayed, estimates need to be lowered: Analyst
Patrick Scholes of Truist joins CNBC's Kelly Evans to break down why recovery in corporate travel is crucial for the sector overall. For access to live and exclusive video from CNBC subscribe to CNBC ...
Axon Capital's Singh sees vaccine boosting travel, entertainment stocks
Services company stocks, especially those linked to travel and leisure, have room to rocket higher next year as consumers venture out again after spending on goods but cutting back on services during ...
This Will Be Worst Year Ever for Hotels, Says AHLA's Rogers
Nov.25 -- Chip Rogers, American Hotel and Lodging Association chief executive officer, says hotels may not see a rebound begin until April of next year. He speaks on "Balance of Power.
Thanksgiving travel seeing 'biggest decline' since 2008 recession: AAA
Paula Twidale, senior vice president-travel for AAA, on what to expect for Thanksgiving travel amid the coronavirus pandemic. Subscribe to Fox Business!
Travel, Leisure Overexposed in Vaccine Rally, Strategist Hogan
Nov.24 -- Art Hogan, chief market strategist at National Securities, discusses balancing a portfolio in markets driven by vaccine euphoria. He speaks on "Bloomberg Markets.
Travel stocks rally after Moderna's vaccine progress lifts hopes for near-term reopening
Airline, hotel, and cruise stocks surged in early Monday trading as Moderna's encouraging vaccine trial results spurred fresh optimism for an end to the coronavirus pandemic. The biotech company annou...
Airline, hotel, and travel stocks poised for Monday rally on Pfizer vaccine news
Everything's up in the air right now. Health experts have long warned us not to get too excited about vaccine trials before the full range of data can be examined, but investors in the travel industry...